MedPath

Effect of N-acetyl cysteine on expression of Oxidation-Reduction genes during implantation window in women with Recurrent Implantation Failure

Phase 2
Conditions
Female Infertility.
Female infertility
Registration Number
IRCT20150831023831N2
Lead Sponsor
Royan Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
44
Inclusion Criteria

Age between 20 and 40 years
At least twice implantation failure
BMI in the normal range
Patients prescribed drugs such as folic acid, iron, multivitamins, and supplements generally equal status

Exclusion Criteria

Irregular menstrual cycle
Taking hormonal drugs except thyroid medication
Patients with abnormal karyotype or chromosomal disorders
Patients who have coagulation problems

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gene expression related to implantation. Timepoint: 9 weeks after intervention. Method of measurement: Real-time PCR.
Secondary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 2 weeks after Embryo Transfer. Method of measurement: Measurement of quantitative serum ß-hCG.
© Copyright 2025. All Rights Reserved by MedPath